Background: Mutations in the Beta-glucocerebrosidase (GBA) gene are the most common genetic risk factor for Parkinson’s disease (PD). GBA-associated PD (GBA-PD) has been linked to a higher prevalence of non-motor symptoms compared to idiopathic PD (I-PD), raising the question of whether autonomic dysfunction is more frequent or expressed differently in GBA-PD patients. Objectives: This study aimed to investigate cardiovascular autonomic function in GBA-PD patients compared to I-PD patients. The primary objective was to evaluate the prevalence and severity of cardiovascular dysautonomia in GBA-PD patients. Secondary objectives included determining whether dysautonomia primarily affects the sympathetic, parasympathetic, or both systems and performing a genotype-phenotype analysis to explore whether individuals with severe GBA variants are at a greater risk for cardiovascular dysautonomia. Methods: The frequency and severity of autonomic symptoms were measured using the SCOPA-AUT questionnaire. Cardiovascular autonomic reflex testing was conducted in an autonomic laboratory using standard clinical protocols. Spectral analysis of heart rate variability was performed to assess sympatho-vagal balance and vagal tone in both supine and standing positions. Additionally, 123I-MIBG myocardial single-photon emission CT was used to evaluate postganglionic sympathetic nerve terminals. Results: A total of 34 GBA carriers and 33 I-PD patients were included. GBA-PD patients exhibited greater severity of autonomic symptoms compared to the I-PD cohort, as indicated by the SCOPA-AUT questionnaire results. Autonomic testing revealed increased parasympathetic impairment in the GBA-PD group, which was confirmed by spectral analysis showing reduced vagal modulation. The degree of sympathetic cardiac denervation was comparable between the two groups. Conclusions: This study provides evidence of autonomic dysfunction in both GBA-PD and I-PD patients, with a particular emphasis on parasympathetic impairment in the GBA-PD population. Genotype-phenotype analysis did not identify a correlation between the severity of GBA mutations and cardiovascular autonomic dysfunction.

CARDIOVASCULAR AUTONOMIC IMPAIRMENT IN GBA PARKINSONIAN PATIENTS / A. Cocco ; tutor: A. Albanese, G. Comi ; coordinatore: C. Sforza. - V. Mangiagalli, 32, Città Studi. Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, 2024 Jun 10. 36. ciclo, Anno Accademico 2023.

CARDIOVASCULAR AUTONOMIC IMPAIRMENT IN GBA PARKINSONIAN PATIENTS

A. Cocco
2024

Abstract

Background: Mutations in the Beta-glucocerebrosidase (GBA) gene are the most common genetic risk factor for Parkinson’s disease (PD). GBA-associated PD (GBA-PD) has been linked to a higher prevalence of non-motor symptoms compared to idiopathic PD (I-PD), raising the question of whether autonomic dysfunction is more frequent or expressed differently in GBA-PD patients. Objectives: This study aimed to investigate cardiovascular autonomic function in GBA-PD patients compared to I-PD patients. The primary objective was to evaluate the prevalence and severity of cardiovascular dysautonomia in GBA-PD patients. Secondary objectives included determining whether dysautonomia primarily affects the sympathetic, parasympathetic, or both systems and performing a genotype-phenotype analysis to explore whether individuals with severe GBA variants are at a greater risk for cardiovascular dysautonomia. Methods: The frequency and severity of autonomic symptoms were measured using the SCOPA-AUT questionnaire. Cardiovascular autonomic reflex testing was conducted in an autonomic laboratory using standard clinical protocols. Spectral analysis of heart rate variability was performed to assess sympatho-vagal balance and vagal tone in both supine and standing positions. Additionally, 123I-MIBG myocardial single-photon emission CT was used to evaluate postganglionic sympathetic nerve terminals. Results: A total of 34 GBA carriers and 33 I-PD patients were included. GBA-PD patients exhibited greater severity of autonomic symptoms compared to the I-PD cohort, as indicated by the SCOPA-AUT questionnaire results. Autonomic testing revealed increased parasympathetic impairment in the GBA-PD group, which was confirmed by spectral analysis showing reduced vagal modulation. The degree of sympathetic cardiac denervation was comparable between the two groups. Conclusions: This study provides evidence of autonomic dysfunction in both GBA-PD and I-PD patients, with a particular emphasis on parasympathetic impairment in the GBA-PD population. Genotype-phenotype analysis did not identify a correlation between the severity of GBA mutations and cardiovascular autonomic dysfunction.
10-giu-2024
Parkinson's disease; , glucocerebrosidase; dysautonomia; non-motor symptoms
Settore MED/26 - Neurologia
Settore MEDS-12/A - Neurologia
COMI, GIACOMO PIETRO
SFORZA, CHIARELLA
Doctoral Thesis
CARDIOVASCULAR AUTONOMIC IMPAIRMENT IN GBA PARKINSONIAN PATIENTS / A. Cocco ; tutor: A. Albanese, G. Comi ; coordinatore: C. Sforza. - V. Mangiagalli, 32, Città Studi. Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, 2024 Jun 10. 36. ciclo, Anno Accademico 2023.
File in questo prodotto:
File Dimensione Formato  
phd_unimi_R13178.pdf

Open Access dal 01/03/2025

Descrizione: Tesi di dottorato
Tipologia: Publisher's version/PDF
Dimensione 2.17 MB
Formato Adobe PDF
2.17 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1121075
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact